These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12510773)
1. cDNA array analysis of SPARC-modulated changes in glioma gene expression. Golembieski WA; Rempel SA J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773 [TBL] [Abstract][Full Text] [Related]
2. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067 [TBL] [Abstract][Full Text] [Related]
3. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657 [TBL] [Abstract][Full Text] [Related]
4. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Golembieski WA; Ge S; Nelson K; Mikkelsen T; Rempel SA Int J Dev Neurosci; 1999; 17(5-6):463-72. PubMed ID: 10571408 [TBL] [Abstract][Full Text] [Related]
7. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas. Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074 [TBL] [Abstract][Full Text] [Related]
10. SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions. Vadlamuri SV; Media J; Sankey SS; Nakeff A; Divine G; Rempel SA Neuro Oncol; 2003 Oct; 5(4):244-54. PubMed ID: 14565160 [TBL] [Abstract][Full Text] [Related]
11. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Zhou Y; Hofstetter WL; He Y; Hu W; Pataer A; Wang L; Wang J; Zhou Y; Yu L; Fang B; Swisher SG Cancer Biol Ther; 2010 Apr; 9(7):507-13. PubMed ID: 20215880 [TBL] [Abstract][Full Text] [Related]
12. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936 [TBL] [Abstract][Full Text] [Related]
13. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma. McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076 [TBL] [Abstract][Full Text] [Related]
14. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells. Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775 [TBL] [Abstract][Full Text] [Related]
15. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells. Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659 [TBL] [Abstract][Full Text] [Related]
17. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. Mariani L; Beaudry C; McDonough WS; Hoelzinger DB; Demuth T; Ross KR; Berens T; Coons SW; Watts G; Trent JM; Wei JS; Giese A; Berens ME J Neurooncol; 2001 Jun; 53(2):161-76. PubMed ID: 11716068 [TBL] [Abstract][Full Text] [Related]
18. Glioma-astrocyte interaction modifies the astrocyte phenotype in a co-culture experimental model. Gagliano N; Costa F; Cossetti C; Pettinari L; Bassi R; Chiriva-Internati M; Cobos E; Gioia M; Pluchino S Oncol Rep; 2009 Dec; 22(6):1349-56. PubMed ID: 19885586 [TBL] [Abstract][Full Text] [Related]
19. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807 [TBL] [Abstract][Full Text] [Related]
20. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. Menon PM; Gutierrez JA; Rempel SA Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]